CVS Health Corporation (CVS)
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
CVS drops Lilly's Zepbound
CNBC's Angelica Peebles reports on news regarding CVS.
Tracking the 3 Best Dividend Stocks in 2025
With the first half of 2025 wrapped up, now feels like as good a time as any to check in with the top-performing dividend plays and see how the stage is set for the rest of the year.
Will CVS Health's Formulary Move Boost Its Weight Management Program? (Revised)
CVS adds Wegovy to its top formularies and bolsters its Weight Management program, aiming to expand access while cutting costs.
Are Medical Stocks Lagging CVS Health (CVS) This Year?
Here is how CVS Health (CVS) and Agenus (AGEN) have performed compared to their sector so far this year.
3 High-Yield Dividend Kings Beating the S&P 500 This Year
The S&P 500 is one of the most widely known benchmarks. It contains the 500 most valuable publicly traded U.S.
CVS Health (CVS) Laps the Stock Market: Here's Why
CVS Health (CVS) closed the most recent trading day at $67.58, moving +1.15% from the previous trading session.
Why CVS Health (CVS) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Exploring CVS' Health Services Segment: A Key Growth Engine for 2025?
CVS' Health Services segment posts $43B in revenues as specialty pharmacy and Caremark deals drive 2025 growth prospects.
CVS Surges on Regulatory Relief, Medicare Advantage Push: Time to Buy?
CVS surges 53.7% YTD as regulatory relief, strong execution and Medicare Advantage momentum fuel investor confidence.
5 Low Price-to-Book Value Stocks That You Can Buy in June
The P/B ratio helps to identify low-priced stocks with high growth prospects. USNA, CVS, PFE, STNE and PSFE are some such stocks.
